1-3 of 3
Jesus Ojanguren
Close
Sort by
Journal Articles

Validation of the Response Speed Rule to Predict the Efficacy of a Therapeutic Regimen in Myeloma

Jose Enrique De La Puerta Rueda, MD, Clara Gómez Pérez, MD, Concepción Velado Rodriguez, Tomas Carrascosa Vallejo, MD, Begoña Sancho Garaizabal, MD, Maria José Ereño Ealo, MD, Elixabete Pastor Ausin, MD, Isabel Uriarte, MD, Iñigo Vicente Olabarria, MD, Alberto Cabrera Zubizarreta, MD, José María Ontañón Garcés, MD, Ibone Saralegui Prieto, MD, Matxalen Olivares Salaverri, MD, Inmaculada Barredo Santamaría, MD, Alberto Sáiz López, MD, Paula Arana Berganza, MD, Natalia Maruri Machado, MD, Raquel Pérez Garay, MD, Eloisa Urrechaga Igartua, MD, Ianire Etxeguren Urkixo, MD, Garazi Letamendi Madariaga, MD, Cristina Martínez Bilbao, MD, Itxaso Amarika Ibarrondo, MD, Amaia Casado Diez, MD, Inés González Vallejo, MD, Cristina Cortes Fernández, MD, Eukene Gainza González, MD, Jesus Ojanguren Bergaz, MD, Paloma Ibarrondo Chamorro, MD, Ane Aranbarri Chamorro, MD, Javier Goikolea Ugarte, Pharm, Miriam Bustos Martínez, Pharm, Amaia Sierra Zabala, Urko Aguirre Larracoechea, Marta Alonso Varela, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–44.
https://doi.org/10.1182/blood-2020-138555
Published: 2020
Journal Articles

Precision Medicine Based on the Achievement of Sustained Undetectable Minimal Residual Disease (MRD) By Next-Generation Flow (NGF) and Imaging Leads to Significant Reduction in Risk of Progression of Patients with Multiple Myeloma (MM)

Jose Enrique De La Puerta Rueda, MD, Leire Burgos, Garazi Letamendi Madariaga, MD, Cristina Martinez Bilbao, MD, Luis Atutxa Aresti, MD, Jesus Ojanguren Bergaz, MD, Matxalen Olivares Salaverri, MD, Begoña Sancho Garaizabal, MD, Isabel Uriarte, MD, Iñigo Vicente Olabarria, MD, Raquel Pérez Garay, MD, Ana de Juan Arroyo, Pharm, Itxaso Amarika Ibarrondo, MD, Tomas Carrascosa Vallejo, MD, Amaia Casado Diez, MD, Cristina Cortes Fernández, MD, Ianire Etxeguren Urkixo, MD, Eukene Gainza González, MD, Inés González Vallejo, MD, Javier Goikolea Ugarte, Pharm, Inmaculada Barredo Santamaría, MD, Alberto Sáiz López, MD, Antonio Vázquez Rodríguez, MD, Eloisa Urrechaga Igartua, MD, Maria José Ereño Ealo, MD, Estibalitz Montejo Rodrigo, MD, Elixabete Pastor Ausin, MD, Alberto Cabrera Zubizarreta, MD, José María Ontañón Garcés, MD, Ibone Saralegui Prieto, MD, Natalia Maruri Machado, MD, Paula Arana Berganza, MD, Mara Celis Alvarez, MD, Ane Aranbarri Larrañaga, MD, Paloma Ibarrondo Chamorro, MD, Bruno Paiva, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3170.
https://doi.org/10.1182/blood-2019-125062
Published: 2019
Journal Articles

Prolonged Survival in Patients with Angioimmunoblastic T-Cell Lymphoma (AIL) after High-Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT). The GELTAMO Experience.

Jose Rodriguez, Maria Dolores Caballero, Antonio Gutierrez, Marco Gandarillas, Angel Leon, Jesus Ojanguren, Ana Sureda, Armando Lopez-Guillermo, Dolores Carrera, Mauricio Bendandi, Reyes Arranz, Jose Moraleda, Jose Maria Ribera, Carmen Albo, Alfonso Morales, Juan Carlos Garcia, Pascual Fernandez, Guillermo Cañigral, Juan Bergua, Eulogio Conde
Journal: Blood
Blood (2005) 106 (11): 2082.
https://doi.org/10.1182/blood.V106.11.2082.2082
Published: 2005